CVRdatabase
Menu

Cystotech ApS

Private limited companyCVR 42773565Aarhus CActive

Cystotech ApS is a private limited company, based in Aarhus C, active in research and experimental development on natural sciences and engineering, founded in 2021. The company made a loss in both 2024 and 2025, most recently DKK 4.4m. Equity grew to DKK 24.8m in 2025. 7 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 1.5m+74.2% vs. 2024
Net profit−DKK 4.4m−26.9% vs. 2024
EquityDKK 24.8m+161.6% vs. 2024
Employees14latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 74% (2024 → 2025), to DKK 1.5m.
  • The loss grew: from DKK 3.5m to DKK 4.4m (2024 → 2025).
  • Equity rose 162% (2024 → 2025), to DKK 24.8m.

Employees

  • 6 fewer employees than a year earlier: 14 (07/2026) against 20 (07/2025).

Management and owners, last 24 months

  • New in management: Anna Munk Nielsen (director, 01/10/2025).
  • Stepped down: Jacob Elmose Jensen (director, 30/09/2025).
  • New owners registered: Cystotech Invest II ApS (12/03/2025) and Innovations A/S (02/12/2025).
  • No longer registered as owner: Innovations A/S (18/12/2025).

Registrations, last 24 months

  • 18/12/2025: Share capital changed from 73,374 DKK to 77,057 DKK
  • 02/12/2025: Share capital changed from 66,280 DKK to 73,374 DKK
  • 12/03/2025: Share capital changed from 59,274 DKK to 66,280 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2022–2025 · amounts in DKK thousand

Equity and net profit

−DKK 5mDKK 0DKK 5mDKK 10mDKK 15mDKK 20mDKK 25m2022202320242025
EquityNet profit
Financial figures for Cystotech ApS
2022202320242025Change
Revenuenot statednot statednot statednot stated–
Gross profit7651,6128771,528+74.2%
Operating profit (EBIT)−625−1,714−4,030−5,050−25.3%
Profit before tax−808−2,116−4,495−5,557−23.6%
Net profit−538−1,597−3,454−4,382−26.9%
Total assets8,15313,62116,54032,169+94.5%
Equity4,1197,6039,49524,841+161.6%
Liabilities3,9985,8107,0067,328+4.6%
Cash and cash equivalents6,3916,9903,082617−80%
Average number of employees34710+42.9%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 200kDKK 400kDKK 600kDKK 800kDKK 1mDKK 1.2mDKK 1.4mDKK 1.6m2022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 4 years in a row

    Net result has been negative in 2022–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

4 financial years
Annual reports for Cystotech ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202516/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202416/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202323/06/2024The companyPDFXBRL
202220/10/2021 – 31/12/202214/06/2023The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0510152008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 1.5mNo. 180 of 421
Better than 57% of the companies in the industry
EquityDKK 24.8mNo. 93 of 431
Better than 79% of the companies in the industry
Number of employees14No. 142 of 431
Better than 67% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 36,525of 69,742
Better than 48%
No. 5,036of 69,964
Better than 93%
Same industry and fewer than 20 employees329 companies in the comparison
No. 107of 323
Better than 67%
No. 32of 329
Better than 91%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 19,476of 33,588
Better than 42%
No. 1,989of 33,687
Better than 94%
All companies of type ApS66,508 companies in the comparison
No. 35,280of 66,379
Better than 47%
No. 3,630of 66,505
Better than 95%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Cystotech ApSDKK 1.5m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Cystotech ApS−DKK 4.4m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Cystotech ApSDKK 24.8m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Cystotech ApS14
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Skovly-Munk Holding ApS10%
  • CH Medinvest ApS5%
  • Den Midtjyske Iværksætterfond5%
  • h6capital ApS5%
  • Cloudbeam Holding ApS10%
  • Cajbo ApS20%
  • Cystotech Invest ApS10%
  • Cystotech Invest II ApS5%
Cystotech ApS

Management

8 active registrations

Executive management

Executive management at Cystotech ApS
NameRoleAppointed
Claus HansenDirector21/06/2024
Anna Munk NielsenDirector01/10/2025

Board of directors

Board of directors at Cystotech ApS
NameRoleAppointed
Jacob Elmose JensenBoard member20/10/2021
Ole Niels Jakob JensenBoard member05/05/2022
Brian HedegaardBoard member05/05/2022
Claus HansenBoard member11/06/2024
Lars Christian LundChair of the board11/06/2024
Nazarena MazzaroBoard member01/10/2024
Founders
Cloudbeam Holding ApS, CH Medinvest ApS, h6capital ApS, Cajbo ApS, Skovly-Munk Holding ApS
Former management (4)
Former management at Cystotech ApS
NameRoleAppointedResigned
Claus HansenChair of the board20/10/202110/06/2024
Jacob Elmose JensenDirector20/10/202130/09/2025
Anna Munk NielsenBoard member20/10/202105/05/2022
Lars Christian LundBoard member21/12/202310/06/2024

Signing rule: Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør, af to bestyrelsesmedlemmer eller af den samlede bestyrelse.

Address and production units

1 active production units

Inge Lehmanns Gade 10
8000 Aarhus C

Aarhus Municipality · Postcode 8000

Other companies at the address (7)

Production units
Production unitAddressEmployeesP number
Cystotech ApSInge Lehmanns Gade 10, 5, 8000 Aarhus C151027652049

Purpose

Selskabets formål er at drive udviklings- og forskningsvirksomhed indenfor det sundhedsfaglige område samt efter bestyrelsens skøn dermed beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

56 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
202510 changescapital 3 · ownership 3 · management 2 · accounts 1 · industry 1
  • Share capital changed from 73,374 DKK to 77,057 DKK
  • INNOVATIONS A/S is no longer registered as owner
  • Share capital changed from 66,280 DKK to 73,374 DKK
  • INNOVATIONS A/S registered as owner (5%)
  • Anna Munk Nielsen appointed director
  • Jacob Elmose Jensen stepped down as director
  • Annual report for 2024 published
  • Share capital changed from 59,274 DKK to 66,280 DKK
  • Cystotech Invest II ApS registered as owner (5%)
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
202414 changesmanagement 6 · capital 2 · accounts 1 · ownership 4 · address 1
  • Nazarena Mazzaro appointed board member
  • Share capital changed from 58,293 DKK to 59,274 DKK
  • Annual report for 2023 published
  • Claus Hansen appointed director
  • Share capital changed from 53,975 DKK to 58,293 DKK
  • Lars Christian Lund appointed chair of the board
  • Claus Hansen appointed board member
  • Cystotech Invest ApS registered as owner (10%)
  • Cajbo ApS registered as owner (20%)
  • Lars Christian Lund stepped down as board member
  • Claus Hansen stepped down as chair of the board
  • Cajbo ApS is no longer registered as owner
  • Cystotech Invest ApS is no longer registered as owner
  • Moved to Inge Lehmanns Gade 10, 5, 8000 Aarhus C
202312 changesmanagement 1 · capital 1 · ownership 9 · accounts 1
  • Lars Christian Lund appointed board member
  • Share capital changed from 47,600 DKK to 53,975 DKK
  • CH MEDINVEST ApS registered as owner (5%)
  • Den Midtjyske Iværksætterfond registered as owner (5%)
  • h6capital ApS registered as owner (5%)
  • Skovly-Munk Holding ApS registered as owner (10%)
  • Cloudbeam Holding ApS registered as owner (10%)
  • h6capital ApS is no longer registered as owner
  • CH MEDINVEST ApS is no longer registered as owner
  • Cloudbeam Holding ApS is no longer registered as owner
  • Skovly-Munk Holding ApS is no longer registered as owner
  • Annual report for 2022 published
20229 changescapital 2 · ownership 3 · address 1 · management 3
  • Share capital changed from 43,040 DKK to 47,600 DKK
  • Cajbo ApS registered as owner (25%)
  • Cystotech Invest ApS registered as owner (10%)
  • Cajbo ApS is no longer registered as owner
  • Moved to Inge Lehmanns Gade 10, 5, 8000 Aarhus C
  • Share capital changed from 40,000 DKK to 43,040 DKK
  • Ole Niels Jakob Jensen appointed board member
  • Brian Hedegaard appointed board member
  • Anna Munk Nielsen stepped down as board member
202110 changesfounded 1 · management 4 · ownership 5
  • Registered as Cystotech ApS
  • Claus Hansen appointed chair of the board
  • Jacob Elmose Jensen appointed board member
  • Anna Munk Nielsen appointed board member
  • Jacob Elmose Jensen appointed director
  • Cajbo ApS registered as owner (33.33%)
  • h6capital ApS registered as owner (10%)
  • CH MEDINVEST ApS registered as owner (10%)
  • Cloudbeam Holding ApS registered as owner (20%)
  • Skovly-Munk Holding ApS registered as owner (15%)

Related companies

Same industry in Aarhus

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction